Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. May 27, 2022; 14(5): 992-1005
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.992
Table 1 Baseline characteristics of patients and treatment
Baseline characteristic
n = 87
Age (IQR, yr)63.5 (26.0-68.0)
Sex, n (%) Male55 (63.2)
Female32 (36.8)
ASA-PS, n (%)124 (27.6)
244 (50.6)
319 (21.8)
Primary disease, n (%)Pancreatic cancer58 (66.7)
Bile duct cancer9 (10.3)
Gallbladder cancer2 (2.3)
Ampullary cancer2 (2.3)
Duodenal cancer2 (2.3)
Other cancers14 (16.1)
Clinical stage, n (%)II3 (3.5)
III9 (10.3)
IV75 (86.2)
Chemotherapy, n (%)Yes48 (55.2)
Radiotherapy, n (%)Yes11 (12.6)
Total bilirubin level (IQR, mg/dL)3.8 (2.1-7.7)
Length of stricture (IQR, mm)31.5 (21.8-39.3)
Total procedure time (IQR, min)32.0 (24.5-48.5)
EST, n (%)Yes60 (69.0)
CSEMS type (1), n (%)Partially38 (43.7)
Fully49 (56.3)
CSEMS type (2), n (%)Laser-cut6 (6.9)
Braided81(93.1)
Length of CSEMS (cm), n (%)43 (3.5)
51 (1.1)
644 (50.6)
710 (11.5)
829 (33.3)
Diameter of CSEMS (mm), n (%)63 (3.5)
83 (3.5)
1081 (93.0)
Angle of CSEMS (IQR, °)146.0 (134.5-156.5)

  • Citation: Tanoue K, Maruyama H, Ishikawa-Kakiya Y, Kinoshita Y, Hayashi K, Yamamura M, Ominami M, Nadatani Y, Fukunaga S, Otani K, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Watanabe T, Fujiwara Y. Angle of covered self-expandable metallic stents after placement is a risk factor for recurrent biliary obstruction. World J Hepatol 2022; 14(5): 992-1005
  • URL: https://www.wjgnet.com/1948-5182/full/v14/i5/992.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v14.i5.992